Trial Profile
Effect of lenalidomide and its association with primary malignancies in Moffitt Cancer Center patients with Multiple Myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2018
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 29 Jan 2018 New trial record